New Search

If you are not happy with the results below please do another search

2034 search results for:

1921

Collaboration to advance noninvasive risk assessments of pregnancy outcomes

Thermo Fisher Scientific and NX Prenatal Inc., a recognized leader in the detection, monitoring and management of pregnancy-related complications using novel exosome-based methods, have entered into a collaboration to develop clinical mass spectrometry-based proteomics assays to monitor fetal health in utero and assess the risk of adverse outcomes, including preterm birth and preeclampsia. This new […]

1922

The microbiota in the intestines fuels tumour growth

The team of Professor Dirk Haller at the Technical University of Munich (TUM) made an unexpected discovery while investigating the triggering factors of colon cancer:  Cell stress in combination with an altered microbiota in the colon drives tumour growth.  Previously, it was assumed that this combination only contributes to inflammatory intestinal diseases. "With our study […]

1924

New blood test may map fetal genome for countless mutations

Tel Aviv University researchers have developed a new blood test for genetic disorders that may allow parents to learn about the health of their baby as early as 11 weeks into pregnancy.The simple blood test lets doctors diagnose genetic disorders in fetuses early in pregnancy by sequencing small amounts of DNA in the mother’s and […]

1925

Viral RNA sensing

Even tiny amounts of viruses can have disastrous consequences. RNA identification can reveal the type of virus present. A fast and sensitive technique based on optical detection has now been outlined. Scientists from Germany and Finland have demonstrated the binding of an RNA target to a probe made of gold nanorods and a DNA origami […]

1926

Unlocking the female bias in lupus

New research on the X chromosome from the School of Veterinary Medicine points to an abnormality in the immune system’s T cells as a possible contributing factor in lupus and other autoimmune diseases. The autoimmune disease lupus, which can cause fatigue, a facial rash, and joint pain, strikes females far more often than males. Eight-five […]

1927

Treponema Pallidum tests global market to reach $462m by 2028

The global Treponema Pallidum (or Syphilis) tests market is projected to reach $462m by 2028, growing at a Compound Annual Growth Rate (CAGR) of 2.99% between 2018 and 2028, according to GlobalData, a leading data and analytics company.The company’s latest report, ‘Treponema Pallidum Tests – In Vitro Diagnostics Tests Analysis and Forecast Model’ reveals that […]

1928

FDA grants Breakthrough Device Designation for Roche’s Elecsys cerebrospinal fluid (CSF) assays to support diagnosis of Alzheimer’s disease

Roche announced in July that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Device Designation to Elecsys® ß-Amyloid (1-42) CSF and Elecsys® Phospho-Tau (181P) CSF. These in vitro diagnostic immunoassays are for the measurement of the ß-Amyloid (1-42) and Phospho-Tau concentrations in cerebrospinal fluid (CSF) in adult patients with cognitive impairment who are […]

1929

Protein content as a marker for response to therapy in brain cancer

Brain tumours vary widely in how they respond to treatment. However, early assessment of therapy response is essential in order to choose the best possible treatment for the patient. Scientists from the German Cancer Research Center (DKFZ) have now been able to show in a study using non-invasive high-resolution 7-Tesla MRI scans that the protein […]

1930

New genetic test improves safety of Inflammatory Bowel Disease treatments

A genetic discovery will make treatment for Crohn’s disease and ulcerative colitis safer, by identifying patients who are at risk of potentially deadly drug side effects. A ground-breaking and large-scale NHS research collaboration, led by the University of Exeter and the Royal Devon & Exeter NHS Foundation Trust, has discovered a gene mutation that allows […]